Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: Delayed skin test and ELISPOT assay results allow the identification of the culprit drug-Reference-Cited by-同舟云学术

Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: Delayed skin test and ELISPOT assay results allow the identification of the culprit drug

Published:2012-12 Issue:6 Volume:130 Page:1413-1414
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Bensaid Benoit,Rozieres Aurore,Nosbaum Audrey,Nicolas Jean-François,Berard Frédéric

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference7 articles.

1. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure;Eshki;Arch Dermatol,2009

2. A rare case of streptomycin-induced toxic epidermal necrolysis in a patient with tuberculosis: a therapeutic dilemma;Hmouda;Ann Pharmacother,2005

3. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist;Kardaun;Br J Dermatol,2007

4. Epicutaneous patch-testing;Devos;Eur J Dermatol,2002

5. Detection and quantification of drug-specific T cells in penicillin allergy;Rozieres;Allergy,2009

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical algorithm: Diagnosis and treatment of drug reaction with eosinophilia and systemic symptoms in adult patients;Allergy;2024-04-08

2. Tools for Etiologic Diagnosis of Drug-Induced Allergic Conditions;International Journal of Molecular Sciences;2023-08-08

3. Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions;Frontiers in Medicine;2022-10-13

4. Patch testing in drug reaction with eosinophilia and systemic symptoms ( DRESS ): A literature review;Contact Dermatitis;2022-03-29

5. Patch Testing in Drug Eruptions: Practical Aspects and Literature Review of Eruptions and Culprit Drugs;Dermatitis;2022-01